image
Healthcare - Biotechnology - NASDAQ - US
$ 1.21
-3.97 %
$ 20.4 M
Market Cap
-0.95
P/E
CASH FLOW STATEMENT
-37.1 M OPERATING CASH FLOW
27.32%
60.5 M INVESTING CASH FLOW
346.47%
-16.3 M FINANCING CASH FLOW
-29.79%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Unity Biotechnology, Inc.
image
Net Income -39.9 M
Depreciation & Amortization 1.18 M
Capital Expenditures -11 K
Stock-Based Compensation 7.42 M
Change in Working Capital -4.39 M
Others -5.42 M
Free Cash Flow -37.1 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (39.9) (59.9) (60.7) (93.8) (82.2) (76.4) (44.7) (30.4)
Depreciation & Amortization 1.2 2.2 2.9 3.4 2.7 2.2 1.3 0.2
Deferred Income Tax 0 0 0.9 2.4 (6.9) (1.5) (0.4) 9.0
Stock Based Compensation 7.4 9.4 11.6 13.8 10.9 9.4 3.0 0.2
Other Operating Activities (1.4) (1.6) 0.9 0.4 (0.4) 4.5 44 K 2.7
Change in Working Capital (4.4) (1.0) (0.6) (4.6) 3.6 5.1 2.3 2.0
Cash From Operations (37.1) (51.0) (45.1) (78.3) (72.4) (56.6) (38.4) (16.4)
INVESTING CASH FLOW
Capital Expenditures 11 K 96 K (0.2) (0.6) (1.6) (1.3) (1.7) (2.2)
Other Items 60.5 (24.4) 39.5 (4.6) 69.5 (70.9) (84.6) (0.5)
Cash From Investing Activities 60.5 (24.5) 39.3 (5.2) 68.0 (72.2) (86.3) (2.7)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 37 K 0
Total Debt Repaid (20.0) 0 68 K 24.1 73 K 0.8 55 K 16.9
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (1.4) (3.6) 2.3 2.5 1.4 196.0 42.8 91.1
Cash From Financing Activities (16.3) 54.9 20.8 63.9 27.4 136.9 42.8 107.9
CHANGE IN CASH
Net Change In Cash 7.1 (20.7) 15.1 (19.7) 23.0 8.1 (81.9) 88.8
FREE CASH FLOW
Free Cash Flow (37.1) (51.1) (45.3) (79.0) (74.0) (57.9) (40.0) (18.6)